These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29524165)

  • 1. Phospholipid Magnesome-a nasal vesicular carrier for delivery of drugs to brain.
    Natsheh H; Touitou E
    Drug Deliv Transl Res; 2018 Jun; 8(3):806-819. PubMed ID: 29524165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new nanovesicular system for nasal drug administration.
    Touitou E; Duchi S; Natsheh H
    Int J Pharm; 2020 Apr; 580():119243. PubMed ID: 32209370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
    Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
    Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde.
    Tahtat D; Mahlous M; Benamer S; Khodja AN; Oussedik-Oumehdi H; Laraba-Djebari F
    Int J Biol Macromol; 2013 Jul; 58():160-8. PubMed ID: 23567292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
    Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
    Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery.
    Patil SB; Sawant KK
    J Microencapsul; 2009 Aug; 26(5):432-43. PubMed ID: 18932060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticulate assembly of mannuronic acid- and guluronic acid-rich alginate: oral insulin carrier and glucose binder.
    Kadir A; Mokhtar MT; Wong TW
    J Pharm Sci; 2013 Dec; 102(12):4353-63. PubMed ID: 24258282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y; Wei W; Lv P; Wang L; Ma G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of polymer coatings on physicochemical properties of spray-dried liposomes for nasal delivery of BSA.
    Chen KH; Di Sabatino M; Albertini B; Passerini N; Kett VL
    Eur J Pharm Sci; 2013 Nov; 50(3-4):312-22. PubMed ID: 23876823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
    Bento D; Staats HF; Gonçalves T; Borges O
    Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface engineering of silica nanoparticles for oral insulin delivery: characterization and cell toxicity studies.
    Andreani T; Kiill CP; de Souza AL; Fangueiro JF; Fernandes L; Doktorovová S; Santos DL; Garcia ML; Gremião MP; Souto EB; Silva AM
    Colloids Surf B Biointerfaces; 2014 Nov; 123():916-23. PubMed ID: 25466464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
    Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
    Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-loaded alginic acid nanoparticles for sublingual delivery.
    Patil NH; Devarajan PV
    Drug Deliv; 2016; 23(2):429-36. PubMed ID: 24901208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of beads into oral films for buccal and oral delivery of bioactive molecules.
    Castro PM; Sousa F; Magalhães R; Ruiz-Henestrosa VMP; Pilosof AMR; Madureira AR; Sarmento B; Pintado ME
    Carbohydr Polym; 2018 Aug; 194():411-421. PubMed ID: 29801856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery.
    Mukhopadhyay P; Chakraborty S; Bhattacharya S; Mishra R; Kundu PP
    Int J Biol Macromol; 2015 Jan; 72():640-8. PubMed ID: 25239194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
    J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alginate microparticles as novel carrier for oral insulin delivery.
    Reis CP; Ribeiro AJ; Neufeld RJ; Veiga F
    Biotechnol Bioeng; 2007 Apr; 96(5):977-89. PubMed ID: 17001630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel gastroretentive drug delivery system of gliclazide: hollow beads.
    Awasthi R; Kulkarni GT
    Drug Dev Ind Pharm; 2014 Mar; 40(3):398-408. PubMed ID: 23418961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual alginate-lipid nanocarriers as oral delivery systems for amphotericin B.
    Senna JP; Barradas TN; Cardoso S; Castiglione TC; Serpe MJ; Silva KGHE; Mansur CRE
    Colloids Surf B Biointerfaces; 2018 Jun; 166():187-194. PubMed ID: 29602077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel gastroretentive floating particulate drug delivery system of gliclazide.
    Awasthi R; Kulkarni GT
    Curr Drug Deliv; 2012 Sep; 9(5):437-51. PubMed ID: 22920574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.